Innovative radiosurgery system debuts at Ordensklinikum Linz, advancing precision cancer care in the region ...
Hospital Universitario Central de Asturias joins European network to offer innovative acid reflux implant as Implantica scales treatment reach across the region. ...
The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months....
UK hospital becomes first globally to treat patient with new module for online adaptive radiotherapy ...
Middle East's largest healthcare group posts solid growth across all segments, fueled by rising patient volumes, tech innovation, and global expansion...
With strong U.S. demand, a robust radiopharma rollout, and 4% organic revenue growth, CEO Peter Arduini highlights precision care strategy and innovation as GE HealthCare revises guidance under tariff pressures....
![[L-R]: Ms. Vivien Tan, XP Business Manager, Siemens Healthineers ASEAN; Prof. Dr. dr. Lina Choridah, Sp.Rad (K), Chairwoman Indonesian Woman Imaging Society; Hendya Perbangkara, Head of Diagnostic Imaging, Siemens Healthineers Indonesia](/uploads/articles/l_r__ms_vivien_tan_xp_business_manager_siemens_healthineers_asean-24188.jpg)
Introduced at the Indonesian Women Imaging Society event, the new mammography system delivers rapid 50° tomosynthesis for greater diagnostic clarity, enabling earlier detection and improved outcomes for women nationwide....
Unveiled at ESCMID Global Congress 2025, the new Hyperbaric Heating-based platform eliminates the need for extraction kits—delivering faster, simpler, and cost-effective molecular workflows across diverse research and diagnostic applications....
New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025....
With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players. ...
